Key result
Survey reveals ~57% of pharmacists cite workload and limited time as barriers to managing hypertension adherence.
Why the study?
To explore perceptions, behaviours, and barriers of UK pharmacists regarding medication adherence management in hypertension.
What are the perceptions, behaviours, and barriers of UK pharmacists regarding medication adherence management in hypertension?
Cross-Sectional (n=76)
What are the perceptions, behaviours, and barriers of UK pharmacists regarding medication adherence management in hypertension?
UK pharmacists recognize the importance of medication adherence in hypertension but face significant system-level barriers and lack adequate training and tools.
Address patient concerns to boost adherence; reinforces consensus on their role yet leaves open optimal objective tools amid workload barriers.
OBJECTIVE: To explore perceptions, behaviours and barriers of pharmacists in the United Kingdom regarding medication adherence management in hypertension. METHODS: A cross-sectional online questionnaire, adapted from the European Ascertaining Barriers for Compliance (ABC) project, was distributed to UK-registered pharmacists between January and June 2024. The survey included 19 questions across six domains: participant characteristics, beliefs, adherence assessment methods, interventions, barriers, and training. Descriptive analysis was performed. RESULTS: Seventy-six pharmacists responded (53.9% male; 35.5% hospital, 31.6% primary care, 26.3% community). Nearly all (97.4%) agreed that patients' concerns affect adherence. Assessment relied mainly on asking about missed doses (60.5% frequently/always), while objective methods were rarely used, including chemical adherence testing (67.1% never), electronic monitoring (79.8%), and questionnaires (55.4%). Key barriers were high workload (56.6%), limited consultation time (52.6%), and poor interprofessional coordination (51.3%). Most respondents reported insufficient training: 77.3% wanted more undergraduate training and 60.5% had none post-registration; 86.7% did not use guideline recommendations. CONCLUSIONS: UK pharmacists recognise the importance of adherence but lack the time, tools and training to assess it systematically. Addressing system-level barriers and strengthening adherence education are essential to support their expanding role in hypertension management.
No takes yet. Share an insight, caveat, or question.
Osman et al. (2026) conducted a cross-sectional in hypertension (n=76). Online questionnaire was evaluated on perceptions, behaviours and barriers regarding medication adherence management. A cross-sectional survey of 76 UK pharmacists revealed that high workload (56.6%) and limited consultation time (52.6%) are key barriers to managing medication adherence in hypertension.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: